Treating Innovation Risk Differently, Dealing with Uncertainty
Paul Hobcraft
MAY 18, 2016
In this post two, within a three part series, I build the argument on why we need to treat innovation differently within any risk assessment. Part one focused on linking risk into an innovation strategy that needed to align to the corporate one. Is innovation even fully aligned into the corporate strategy?
Let's personalize your content